New insider activity at Boston Scientific ( (BSX) ) has taken place on May 30, 2025.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Director Edward Ludwig has recently sold 4,000 shares of Boston Scientific stock, amounting to a total transaction value of $418,360.
Spark’s Take on BSX Stock
According to Spark, TipRanks’ AI Analyst, BSX is a Outperform.
Boston Scientific’s strong financial performance and positive earnings call are significant strengths, supporting its strategic growth initiatives. However, the high valuation and recent product discontinuation pose risks. Technical indicators show stable momentum, but valuation concerns may limit upside potential.
To see Spark’s full report on BSX stock, click here.
More about Boston Scientific
YTD Price Performance: 16.92%
Average Trading Volume: 8,347,738
Technical Sentiment Signal: Buy
Current Market Cap: $154.6B